Lutera
Product Images NDC 53002-1632

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lutera (NDC 53002-1632). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530021632)

FDA Label Image

Chemical Structure (Lutera 01)

FDA Label Image

Chemical Structure (Lutera 02)

Chemical Structure (Lutera 02)
Ethinyl Estradiol is a synthetic estrogen used in combination with a progestin as an oral contraceptive. It is also used in the treatment of menopausal symptoms such as hot flashes, vaginal dryness, and osteoporosis. It works by preventing ovulation and changing the cervical mucus and uterine lining, making it more difficult for sperm to reach the uterus and for a fertilized egg to attach to the uterus.*
FDA Label Image

Figure I (Lutera 03)

Figure I (Lutera 03)
This is a graph showing the mean levonorgestrel and ethinyl estradiol serum concentrations in 22 subjects receiving Lutera 50 g levonorgestrel and 20 g ethinyl estradiol over the course of 21 days. There is no additional information available from the given text.*
FDA Label Image

Figure Ii (Lutera 04)

Figure Ii (Lutera 04)
The text describes a chart showing circulatory disease mortality rates per 100,000 woman years categorized by age, smoking status, and oral-contraceptive use. The chart includes data for ever-users controls for non-smokers and smokers. The chart contains a scale from 0 to 150. The source of the chart is Lancet, volume 1, pages 541-546 in 1981.*
FDA Label Image

Image (Lutera 05)

Image (Lutera 05)
This is a medication label for Lutera® birth control pills. It includes the National Drug Code (NOC) and indicates that the tablets in week 4 are inactive. The label also instructs the user to follow the arrows when taking the pills.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.